Please rotate the screen for the best
viewing experience. Thank you.

This website was designed with newer technology in mind. Please update your current browser or switch to a recently updated browser. Thank you.

Menu
Filter

Our Mission

We create living systems that emulate human biology to understand and benefit human health.

About Us

Our Human Emulation System sets a new standard for recreating true-to-life human biology and is being used to advance product innovation, design, and safety across a range of applications, including drug development, agriculture, cosmetics, food, and chemical-based consumer products.

We are continuously developing a wide range of Organ-Chips and disease models through collaborations with industry partners and internal R&D programs, and are also working with clinical partners to produce Organ-Chips personalized with individual patients’ stem cells, for applications in precision medicine and personalized health.

Our founding team pioneered Organs-on-Chips technology at the Wyss Institute for Biologically Inspired Engineering at Harvard University. We hold the worldwide exclusive license from Harvard University to a robust and broad intellectual property portfolio for Organs-on-Chips technology and related systems.

close

James Coon

Chief Executive Officer

James Coon is the CEO of Emulate. He is an accomplished entrepreneur who brings over 20 years of experience in founding life sciences companies, developing new products and executing commercialization strategies.

James Coon is the Chief Executive Officer of Emulate and has been in the biotechnology and pharmaceutical industry for over 20 years. Coon has most recently served as Entrepreneur in Residence at the Wyss Institute for Biologically Inspired Engineering at Harvard University, providing researchers with insights on commercialization and product development, target markets, and fundraising strategies in both Nanotherapeutic and Organs-on-Chips technologies.

Coon has served as a co-founder, executive management, and strategic partner for numerous healthcare and biotech startup companies, including roles as President of RxGen, President and CEO of BCS, Inc., President and CEO of HepatoTech, Inc., Executive Vice-President of CellzDirect (acquired by Invitrogen-Life Technologies), and the Senior Director of Business Development for RTI International.

Earlier in his career, Coon held a range of management positions at Fisons Pharmaceutical, Astra Arcus, AstraZeneca, and GlaxoSmithKline. He received his undergraduate degree in Biochemistry from the Rochester Institute of Technology, and completed his graduate work in liver cell biology at the University of North Carolina at Chapel Hill School of Medicine.

close

Geraldine Hamilton

President and Chief Scientific Officer

Geraldine A. Hamilton, Ph.D. serves as the President and CSO of Emulate. She is a recognized cell biologist and toxicologist focused on developing and applying innovative cell-based technologies.

Geraldine A. Hamilton is the President and Chief Scientific Officer of Emulate. Prior to joining Emulate’s founding team, she served as Lead Senior Staff Scientist with the Wyss Institute for Biologically Inspired Engineering at Harvard University. At the Wyss Institute, Hamilton lead the Organs-on-Chips program and managed the multidisciplinary team responsible for developing, translating and commercializing the Organs-on-Chips technology.

Hamilton’s career spans industry, academia and the start-up world. Prior to her tenure at Harvard University, Hamilton spent more than 11 years in the pharmaceutical industry in leadership roles managing drug discovery teams. Her research achievements helped advance the development and application of human relevant in vitro models for drug discovery. Hamilton was a founding scientist and VP of Scientific Operations for CellzDirect, a start-up biotech company that specialized in providing cell products to the pharmaceutical industry for safety testing. Hamilton was responsible for the successful translation of CellzDirect’s technology from academia to broad use and acceptance across the industry.

Hamilton received her Ph.D. in cell biology/toxicology from the University of Hertfordshire (England) in conjunction with GlaxoSmithkline, followed by a post-doctoral research fellowship at the University of North Carolina. She has authored more than 40 publications and numerous patents.

close

Donald Ingber

Scientific Founder, Chair of Scientific Advisory Board

Donald Ingber is a pioneer in the field of Organs-on-Chips. The technology emerged from his leadership as the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University.

Donald Ingber is the Scientific Founder and Chair of the Scientific Advisory Board for Emulate. In addition to his Founding Director role at the Wyss Institute, he is the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences.

Dr. Ingber is recognized as a pioneer of the emerging field of biologically inspired engineering, and oversees efforts at the Wyss Institute that strive to identify the mechanisms that living organisms use to self-assemble, and to apply these principles to develop advanced materials and devices for healthcare and the environment. He led the Organs-on-Chips development program at the Wyss Institute that resulted in the creation of Emulate’s automated bioemulation platform. Dr. Ingber has also made major contributions to mechanobiology, tissue engineering, tumor angiogenesis, systems biology, and nanobiotechnology.

Dr. Ingber has authored more than 375 publications and 85 patents, and has received numerous honors, including the NC3Rs Annual Award from the National Centre for the Replacement, Refinement, and Reduction of Animals in Research, and both the Leading Edge Award and Honorary Membership from the Society of Toxicology. He is also a member of both the American Institute for Medical and Biological Engineering and the Institute of Medicine of the National Academies. Ingber received his B.A., M.A., M.Phil., M.D. and Ph.D. from Yale University.

close

Daniel Levner

Chief Technology Officer

Daniel Levner, Ph.D. is Emulate’s Chief Technology Officer. He is a recognized engineer and biotechnologist with extensive experience in the commercialization of innovative research.

Daniel Levner is Emulate’s Chief Technology Officer. Prior to joining Emulate’s founding team, he was a Senior Staff Scientist with the Wyss Institute for Biologically Inspired Engineering at Harvard University, where he led the advanced engineering team responsible for developing Emulate’s Organs-on-Chips platform. Levner played a key leadership role in managing the multidisciplinary Organs-on-Chips team by formulating innovative approaches for fostering close collaboration and in-depth exchange between biologists and engineers. Levner brings this tight integration of disciplines to Emulate, where it is a defining part of the company’s culture.

Prior to directing the Organs-on-Chips program, Levner worked with world-renowned Harvard geneticist Prof. George M. Church in programs related to medical diagnostics, DNA/RNA sequencing tools, and multiplexed analysis techniques. As an entrepreneur, Levner co-founded a medical diagnostics startup company, and earlier in his career, an optical telecommunications startup company. Levner received his Ph.D. in electrical engineering from Stanford University as well as an M.S. in aeronautics and astronautics, also from Stanford. He has authored numerous publications and more than 20 issued and pending patents.

close

Lewis D. Rowe

Chief Strategist

close

Harry Dhaliwal

Chief Financial Officer

Harry Dhaliwal is an accomplished CFO who brings over 30 years of demonstratable experience leading world class financial structures driving cost, speed, and quality (FCCA certified).

Harry Dhaliwal is the Chief Financial Officer of Emulate. He is an accomplished CFO who brings over 30 years of demonstratable experience leading world class financial structures driving cost, speed, and quality (FCCA certified).

Dhaliwal joined Emulate from Barclays Bank (London and New York) where he was the CFO for Barclays ServCo and responsible for implementing a shared center as well as managing the finance operational activities for the combined Retail (UK) and Investment bank (NY). Prior to this, he held various Senior Executive roles at GE Capital and Industrial, including CFO of GE Inc Global Operations and Global Controllership roles across the Capital Business including GE Treasury. Other key commercial roles included the CEO for Yale Material Handling (Holland and UK) where he Increased market share from 1% to 8% in 12 months by improving ‘Go to Market’ strategy and optimizing sales force effectiveness. Improved Customer satisfaction from 66% - 88% and created a financing JV with GE Capital.

close

Katia Karalis

EVP of Research

close

Stanley King

Vice President of Corporate Development

Stan King aligns the company with strategic growth opportunities that best enable researchers to understand human biology and improve human health.

Stan King is the Vice President of Corporate Development at Emulate. He aligns the company with strategic growth opportunities that best enable researchers to understand human biology and improve human health. King’s interest in how science can improve society has led him to roles at the interface of business strategy, commercialization, intellectual property, and high-impact biomedical research. Prior to joining Emulate, King worked in business development and licensing roles at Boston Children’s Hospital’s Technology Innovation and Development Office, the Wyss Institute for Biologically Inspired Engineering at Harvard University, the MIT Technology Licensing Office, and UVa Innovation. He’s developed intellectual property and licensing strategies, managed multi-party strategic alliances, and executed deals for a variety of life science technologies, all with the goal of commercializing early-stage research discoveries.

King also founded a social enterprise and worked internationally in Kigali, Rwanda with a non-governmental organization developing strategies to foster an entrepreneurship ecosystem as a country-wide development effort. Stan has a B.S. from Florida A & M University and a Ph.D. from the University of Virginia.

close

Zuzu

close

Megan Connolly

Chief of Staff to the CEO

As an ambassador of the company, Megan serves as a liaison for the CEO both internally and externally, including the Board of Directors, Investors, and industry partners.

Megan Connolly is the Chief of Staff to the CEO and oversees the Office of the CEO. As an ambassador of the company, she serves as a liaison for the CEO both internally and externally, including the Board of Directors, Investors, and industry partners. She is responsible for the day to day operations as well as providing strategic direction in regards to administrative, financial, and operational initiatives.

Connolly has served in multiple management roles over the last 8 years within finance, healthcare, and clinical research. Prior to joining Emulate, Megan was at NYU School of Medicine as an Acting Clinical Research Unit Manager and a member of the Association of Clinical Coordination & Research Management (ACCRM) Executive Committee where she directly worked with the university’s IRB to implement and improve clinical research regulations.

Megan has a B.S. in Biological Anthropology with Honors from UMASS Amherst and has a diversified training in project management, first responder medicine (WFR), and clinical research coordination (CCRC).

close

Chris Hinojosa

VP of Platform Development

close

Jermaine Reid

VP of Communications and Events

close

Kyung Jin Jang

VP

close

Stuart Gibb

VP of Sales

Stuart Gibb is the Vice President of Sales at Emulate, and has over 20 years of experience working in life science sales in both Europe and the US.

Stuart Gibb is the Vice President of Sales at Emulate, and has over 20 years of experience working in life science sales in both Europe and the US. He is an accomplished leader who brings experience in building and leading successful sales teams.

Most recently, Gibb served as Director of Sales for the Antibody and Immunoassays System Group at Thermo Fisher Scientific. Before that, he worked for 24 years at Becton Dickinson Company (BD) in multiple roles, including European Sales Leader of BD Biosciences-Imaging Systems and Director of Sales for BD Biosciences Flow Cytometry, where he was based in US. His career started in Scotland as a bio-analytical chemist for Scotlab.

Gibb has built successful teams that have provided scientists in biotech, pharma, and academia with effective and relevant tools that help them produce innovative and important research.

close

Gregory D. Williams

Executive Vice President of Intellectual Property

Greg Williams is Vice President and General Counsel for Emulate. He has a wealth of experience with high-growth biotechnology companies and in intellectual property law.

Greg Williams is Vice President and General Counsel for Emulate, bringing decades of experience in legal practice in the life sciences sector.

Williams is a former partner in the Intellectual Property Practice Group of Pepper Hamilton LLP, with a focus on intellectual property acquisition and management, including IP asset strategy, contracts, licensing portfolio development and management, patent, trademark, technology transfer and strategic alliance negotiation/restructuring. Previously, Williams served as general counsel and a senior member of the global business development team for New England Biolabs, where he was responsible for business development, organizational management and non-IP affairs oversight (employment, compliance, property, etc.) and strategic counseling.

Williams received his undergraduate degree in Chemistry and Biology from McGill University in Montreal, Canada, and his first law degree from McGill University and a Masters of Law (LL.M.) with specialization in intellectual property and anti-trust law from the University of Pennsylvania Law School.

close

Monique Noel

General Counsel

close

Heather Grant

Senior Director of Program Management

close

Jacob Fraser

Associate Director, Scientific Education

close

Remy

close

S. Jordan Kerns

Associate Director

close

Magdalena Kasendra

Associate Director

close

Riccardo Barrile

Associate Director

close

Debora Petropolis

Associate Director

close

Janna Nawroth

Associate Director

close

Carolina Lucchesi

Principal Scientist

close

Lian Leng

Associate Director

close

Sifis Pediaditakis

Principal Scientist

close

Janey Ronxhi

Senior Scientist

close

Konstantia Kodella

Senior Scientist

close

David Conegliano

Senior Scientist

close

Ville Kujala

Principal Scientist

close

Antonio Varone

Principal Scientist

close

Sonalee Barthakur

Scientist II

close

Sauveur Jeanty

Senior Scientist

close

Nasia Apostolou

Research Scholar

close

Chaitra Belgur

Scientist I

close

Gauri Kulkarni

Scientist I

close

Abhishek Shukla

Bioinformatics Scientist

close

Grasiella Andriani

Scientist III

close

Leiam Colbert

Principal Scientist

close

Ruary

close

Raymond Luc

Scientist I

close

Dimitris Manatakis

Biomedical Data Scientist

close

Craig Henshaw

Principal Product Designer II

close

Hector

close

Quinn

close

Marty Laurita

Principal, User Experience Design

close

Aaron Ricica

Senior Product Designer (Hardware)

close

Matthew Corcoran

Associate Director, Content

close

Dani Pachuta

Designer II, Brand Management

close

Doodles

close

Brett Clair

Principal Designer

close

Guy Thompson II

VP of Product and Manufacturing

close

Amanda Payne-Virostko

Director of Product Management

close

Martin Vilarino

Principal, Product Management

close

Mariya Sitnova

Senior Product Manager

close

Jose Fernandez-Alcon

Associate Director, Software

close

Anthony Pisello

Systems Engineer

close

Josiah Sliz

Associate Director

close

Norman Wen

Associate Director

close

Blair Morad

Director of Engineering

close

Grace Ahn

Engineer I

close

Justin Nguyen

Senior Engineer

close

Tanvi Shroff

Engineer II

close

Brian Zuckerman

Engineer I

close

Veronica Betancur-Calle

Engineer II

close

Adele

close

Jefferson Puerta

Engineer II

close

Toby

close

Alexandra Hakim

Designer in Residence

close

Chris Jackson

Intern

close

Mark Young

Operations and Facilities Manager

close

Gimli

close

Joe Burke

Inventory Control Specialist

close

Sheba

close

Patrick Zhu

Manufacturing Manager

close

Phanor Hernandez

Lab Facilities Associate

close

Stella

close

Dinna Sinkus

Housekeeping and Facilities Associate

close

Justin Garabed

Director of Field Service

close

Justin Vega

Field Service Engineer

close

Nasa Suon

Engineer I

close

Marley

close

Trina Cook

Executive Project Manager

close

Sebastian Hernandez

Assistant to the President and Chief Scientific Officer

close

Patrick Cronin

Sales Operations Leader

close

Christine Magyar

VP of Finance

close

Heather Klein

Accounting Manager

close

Sandra Hernandez

Procurement Specialist I

close

Power

close

Sandy Lazzari

EVP of People

close

Stacy Perro

Senior Director, People

close

Mai

close

Anna Walsh

People Coordiantor

close

Swati Kumar

Research Associate

close

Lia Kent

Field Applications Scientist

close

Shahryar Qureshi

Field Applications Scientist

close

Tiffany Hollinger

Project Manager

close

Bruce

close

Yifei Li

Program Manager

close

Scott Gridley

Business Development Executive (Sales)

close

Elliott Johns

Marketing Manager

close

Jessica Kuhar

Business Development Executive (Sales)

close

Oliver Pentinmaki

Business Development Executive

close

Basile Siewe

Business Development Executive

close

Caroline Fanslau

Business Development Executive

close

Sowmya Balasubramanian

Senior Scientist

close

Dwayne Carter

Senior Scientist

close

Sushma Jadalannagari

Senior Scientist

close

Chris Lawson

Field Services

view all show less

Collaborations

We collaborate with our community to continuously advance our technology platform so that it can have impact on patient health across disease research, drug discovery and development, regulatory science, and in the clinic.

learn more

Join our Team

We offer a great rewards package — including competitive pay, options, and bonuses, as well as excellent health benefits, generous paid time-off, a dynamic culture, and opportunities for career development.

For consideration and to meet with our team, please email your resume directly with a short cover letter explaining why you want to work with us, as well as the position you would like to be considered for, to careers@emulatebio.com.

News

Updates about our latest science, publications, partnerships, and products.

latest news
Let's Connect

Emulate, Inc.
HQ: 27 Drydock Ave, Boston, MA 02210
General inquiries:
human@emulatebio.com
Partnering inquiries:
collaborate@emulatebio.com